造血细胞移植后内皮细胞功能及内皮相关疾病
本文综述了造血细胞移植(HCT)后内皮细胞(EC)功能障碍与损伤的病理生理机制,指出凝血因子、细胞因子和黏附分子升高可提示内皮功能障碍,并与肝静脉闭塞病/窦状隙阻塞综合征、移植物抗宿主病、移植相关血栓性微血管病及特发性肺炎综合征/弥漫性肺泡出血等临床并发症相关。内皮是防治HCT并发症的合理靶点,内皮损伤标志物可能有助于改善诊断和监测疗效。
要点
- HCT相关毒性可导致以内皮细胞功能障碍为共同病理生理机制的并发症。
- 凝血因子、细胞因子和黏附分子升高提示内皮功能障碍。
- 内皮损伤可导致VOD/SOS、GVHD、TA-TMA和IPS/DAH等临床表现。
核心结论
- 内皮是预防和治疗由内皮细胞功能障碍和损伤引起的HCT并发症的合理靶点。
- 内皮损伤标志物可能有助于改善HCT相关并发症的诊断和监测治疗效果。
- 持续研究有效管理内皮细胞活化、损伤和功能障碍可能对改善HCT后患者结局具有重要意义。
研究设计与样本
- 综述,检索范围原文未报告。
主要发现
- 凝血因子、细胞因子和黏附分子水平升高提示内皮功能障碍。
- 内皮损伤可导致肝静脉闭塞病/窦状隙阻塞综合征、移植物抗宿主病、移植相关血栓性微血管病及特发性肺炎综合征/弥漫性肺泡出血等HCT后病理状态的临床体征和症状。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Use of haematopoietic cell transplantation (HCT) in the treatment of haematologic and neoplastic diseases may lead to life-threatening complications that cause substantial morbidity and mortality if untreated. In addition to patient- and disease-related factors, toxicity associated with HCT puts patients at risk for complications that share a similar pathophysiology involving endothelial cells (ECs). Normally, the endothelium plays a role in maintaining homeostasis, including regulation of coagulation, vascular tone, permeability and inflammatory processes. When activated, ECs acquire cellular features that may lead to phenotypic changes that induce procoagulant, pro-inflammatory and pro-apoptotic mediators leading to EC dysfunction and damage. Elevated levels of coagulation factors, cytokines and adhesion molecules are indicative of endothelial dysfunction, and endothelial damage may lead to clinical signs and symptoms of pathological post-HCT conditions, including veno-occlusive disease/sinusoidal obstruction syndrome, graft-versus-host disease, transplant-associated thrombotic microangiopathy and idiopathic pneumonia syndrome/diffuse alveolar haemorrhage. The endothelium represents a rational target for preventing and treating HCT complications arising from EC dysfunction and damage. Additionally, markers of endothelial damage may be useful in improving diagnosis of HCT-related complications and monitoring treatment effect. Continued research to effectively manage EC activation, injury and dysfunction may be important in improving patient outcomes after HCT.
引用
- Hildebrandt GC, Chao N. Endothelial cell function and endothelial-related disorders following haematopoietic cell transplantation. Br J Haematol. 2020. PMID: 32319084. doi:10.1111/bjh.16621
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。